By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

A controversial federal shift is reshaping cannabis taxes, boosting some medical-only operators while complicating life for ...

DOJ moves medical cannabis to Schedule III; biotech firms eye funding and IPOs amid banking and tax uncertainty.

The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. ...

Nebraska’s medical cannabis laws could soon be protected from federal interference after all, under a proposed U.S. House ...

How big is the Black-owned cannabis market? The legal cannabis industry generates billions of dollars annually—reaching an ...

Is vaping weed healthier than smoking it? We unpack some benefits, the known harms, and a few unsettling questions sitting ...

The iconic High Times Cannabis Cup competition heads to Atlantic City as New Jersey’s legal cannabis market gains momentum ...

A new study estimates that Hoosiers spend $1.8 billion annually on cannabis products despite living in the most restrictive ...

Researchers at Johns Hopkins and UC San Diego used artificial intelligence to analyze comments in the public record ...